NEW YORK (GenomeWeb News) — IntegraGen today said it has received a €2 million ($2.5 million) equity investment from DSM Venturing, with which it has also signed a research partnership to develop molecular diagnostics.
 
Under the terms of the agreement, IntegraGen will receive upfront fees, licensing fees, and funding to develop gene-based diagnostic and prognostic tests.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.